80 related articles for article (PubMed ID: 33420392)
1. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Domingo-Domenech E; Duarte RF; Boumedil A; Onida F; Gabriel I; Finel H; Arcese W; Browne P; Beelen D; Kobbe G; Veelken H; Arranz R; Greinix H; Lenhoff S; Poiré X; Ribera JM; Thompson J; Zuckerman T; Mufti GJ; Cortelezzi A; Olavarria E; Dreger P; Sureda A; Montoto S
Bone Marrow Transplant; 2021 Jun; 56(6):1391-1401. PubMed ID: 33420392
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.
Goyal A; O'Leary D; Foss F
Bone Marrow Transplant; 2024 Jan; 59(1):41-51. PubMed ID: 37853164
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ;
Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210
[TBL] [Abstract][Full Text] [Related]
4. A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Jacobsen ED; Kim HT; Ho VT; Cutler CS; Koreth J; Fisher DC; Armand P; Alyea EP; Freedman AS; Soiffer RJ; Antin JH
Ann Oncol; 2011 Jul; 22(7):1608-1613. PubMed ID: 21252059
[TBL] [Abstract][Full Text] [Related]
5. Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
Weiner DM; Lewis DJ; Spaccarelli NG; Clark RA; Nasta SD; Loren AW; Rook AH; Kim EJ
Dermatol Ther; 2022 Jul; 35(7):e15538. PubMed ID: 35477952
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan.
Lee CH; Lin TC; Yao M; Hsiao LT; Ko BS; Liu CJ; Chen TY
Cancer Med; 2023 Dec; 12(24):21761-21769. PubMed ID: 38018321
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
Goyal A; Foss F
Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
[TBL] [Abstract][Full Text] [Related]
8. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation.
Zhu P; Lai X; Liu L; Shi J; Yu J; Zhao Y; Yang L; Yang T; Zheng W; Sun J; Wu W; Zhao Y; Cai Z; Huang H; Luo Y
J Transl Med; 2024 Mar; 22(1):275. PubMed ID: 38481248
[TBL] [Abstract][Full Text] [Related]
9. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis.
Beaufils C; Proulx C; Blincoe A; Teira P; Bittencourt H; Cellot S; Duval M; Morin MP; De Bruycker JJ; Couture J; Samaan K; Decaluwe H; Kleiber N; El-Jalbout R; Touzot F; Haddad E; Barsalou J
Front Med (Lausanne); 2023; 10():1275927. PubMed ID: 37908851
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
[TBL] [Abstract][Full Text] [Related]
11. Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome.
Morris SL; Thomas BR; Palanicawandar R; Whittaker S; Child F; Wain M; Sim V; Szydlo R; Mangar S; Olavarria E; Lozano Cerrada S; Muzamil A; Kanfer E
Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38472408
[TBL] [Abstract][Full Text] [Related]
12. Predicting Patient Death after Allogeneic Stem Cell Transplantation for Inborn Errors Using Machine Learning (PREPAD): A European Society for Blood and Marrow Transplantation Inborn Errors Working Party Study.
von Asmuth EGJ; Neven B; Albert MH; Mohseny AB; Schilham MW; Binder H; Putter H; Lankester AC
Transplant Cell Ther; 2023 Dec; 29(12):775.e1-775.e8. PubMed ID: 37709203
[TBL] [Abstract][Full Text] [Related]
13. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.
Mazzeo E; Rubino L; Buglione M; Antognoni P; Magrini SM; Bertoni F; Parmiggiani M; Barbieri P; Bertoni F
Rep Pract Oncol Radiother; 2014 Mar; 19(2):77-91. PubMed ID: 24936325
[TBL] [Abstract][Full Text] [Related]
14. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis.
Luther M; Henes FO; Zabelina T; Massoud R; Janson D; Wolschke C; Klyuchnikov E; Gagelmann N; Fehse B; Adam G; Kröger N; Ayuk F
Bone Marrow Transplant; 2023 Jul; 58(7):755-761. PubMed ID: 37002409
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Assaf C; Illidge TM; Waser N; He M; Li T; Zomas A; Bent-Ennakhil N; Little M; Ortiz-Romero PL; Pimpinelli N; Dalal M; Bagot M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067371
[TBL] [Abstract][Full Text] [Related]
16. How I treat transplant-eligible patients with myelofibrosis.
Kröger N; Wolschke C; Gagelmann N
Blood; 2023 Nov; 142(20):1683-1696. PubMed ID: 37647853
[TBL] [Abstract][Full Text] [Related]
17. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.
Snowden JA; Badoglio M; Labopin M; Giebel S; McGrath E; Marjanovic Z; Burman J; Moore J; Rovira M; Wulffraat NM; Kazmi M; Greco R; Snarski E; Kozak T; Kirgizov K; Alexander T; Bader P; Saccardi R; Farge D; ; ; ;
Blood Adv; 2017 Dec; 1(27):2742-2755. PubMed ID: 29296926
[TBL] [Abstract][Full Text] [Related]
18. Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sézary Syndrome Compared to a Matched Control Cohort.
Johnson CM; Talluru SM; Bubic B; Colbert M; Kumar P; Tsai HL; Varadhan R; Rozati S
JID Innov; 2023 Nov; 3(6):100219. PubMed ID: 38116332
[TBL] [Abstract][Full Text] [Related]
19. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT.
Gjærde LK; Peczynski C; Polge E; Kröger N; de Latour RP; Finke J; Holler E; Blaise D; Helbig G; Salmenniemi U; Potter V; Bunjes D; Erzsebet L; Penack O; Schoemans H; Koenecke C; Basak GW; Perić Z
Bone Marrow Transplant; 2023 Nov; 58(11):1279-1281. PubMed ID: 37612465
[No Abstract] [Full Text] [Related]
20. Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee.
Sharma A; Badawy SM; Suelzer EM; Murthy HS; Prasad P; Eissa H; Carpenter PA; Hamadani M; Labopin M; Schoemans H; Tichelli A; Phelan R; Hamilton BK; Buchbinder D; Im A; Hunter R; Brazauskas R; Burns LJ
Transplant Cell Ther; 2021 May; 27(5):380-388. PubMed ID: 33965174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
